Home › Pulmonary Fibrosis › California › Los Angeles
Pulmonary Fibrosis clinical trials in Los Angeles, CA
4 studies for Pulmonary Fibrosis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RecruitingObservational study
- UCLA, Los Angeles
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Keck School of Medicine of USC, Los Angeles
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Cedars-Sinai, Los Angeles
About Pulmonary Fibrosis
Pulmonary fibrosis (Idiopathic pulmonary fibrosis or IPF) is a condition where the tissue deep in the lungs becomes scarred over time. Find symptoms.
More about Pulmonary Fibrosis on MedlinePlus
Pulmonary Fibrosis trials in other cities
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.